Cassia Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Buy
1,608
+42
+3% +$42.6K 0.76% 31
2025
Q4
$1.68M Sell
1,566
-65
-4% -$62.2K 0.91% 21
2025
Q3
$1.24M Buy
1,631
+213
+15% +$159K 0.68% 37
2025
Q2
$1.11M Sell
1,418
-11
-0.8% -$8.55K 0.66% 35
2025
Q1
$1.18M Buy
1,429
+86
+6% +$71.6K 0.74% 26
2024
Q4
$1.04M Buy
1,343
+329
+32% +$272K 0.66% 27
2024
Q3
$898K Sell
1,014
-91
-8% -$81.8K 0.59% 21
2024
Q2
$1M Sell
1,105
-10
-0.9% -$8K 0.66% 18
2024
Q1
$867K Buy
1,115
+119
+12% +$84.7K 0.58% 25
2023
Q4
$581K Buy
996
+45
+5% +$26.3K 0.48% 27
2023
Q3
$511K Buy
951
+17
+2% +$8.76K 0.42% 28
2023
Q2
$438K Sell
934
-95
-9% -$39.8K 0.35% 37
2023
Q1
$353K Sell
1,029
-11
-1% -$3.71K 0.28% 36
2022
Q4
$380K Sell
1,040
-360
-26% -$128K 0.31% 29
2022
Q3
$453K Buy
1,400
+27
+2% +$8.55K 0.42% 14
2022
Q2
$445K Buy
1,373
+35
+3% +$10.5K 0.44% 18
2022
Q1
$383K Sell
1,338
-10
-0.7% -$2.57K 0.31% 28
2021
Q4
$372K Buy
+1,348
New +$342K 0.25% 28
2021
Q3
Sell
-1,108
Closed -$254K 118
2021
Q2
$254K Buy
+1,108
New +$223K 0.19% 21

Other funds holding LLY

Cassia Capital Partners's LLY Position: Q1 2026 in Review

Cassia Capital Partners increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $42.6K and bringing the position to 1,608 shares worth $1.48M. The position accounts for 0.76% of the portfolio, ranked #31.

Cassia Capital Partners first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.68M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cassia Capital Partners held 1,608 shares of Eli Lilly worth $1.48M as of Q1 2026.
  • Cassia Capital Partners bought 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
  • Eli Lilly made up 0.76% of Cassia Capital Partners's portfolio in Q1 2026, its #31 holding.
  • Cassia Capital Partners first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
  • Cassia Capital Partners's Eli Lilly position peaked at $1.68M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cassia Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.